Neurotargeting, LLC proposes to develop the technical support infrastructure as well as clinical tools for a commercial software product that will provide a global service for the medical community involved in deep brain stimulator (DBS) therapy. Specifically, this Phase I study will explore the use of a physiological atlas database that can interface with a number of institutions performing DBS implants and programming. The computer algorithms that allow for patient specific MRI and CT data as well as any and all physiological data to become integrated into a HIPAA compliant relational database has been initially developed and tested at Vanderbilt University over the past several years. It has changed the efficiency and thought process of DBS implantation in management profoundly at our institution. Although we have tested this within the DBS clinical and surgical group at Vanderbilt, the value of this universal atlas needs to be explored with several other centers which perform and manage DBS implants in diverse ways. This proposal is a logical step in moving towards a commercially available product and service that addresses the needs of the larger DBS community to facilitate data storage and retrieval from a population based atlas. Its purpose is to provide a universal platform to review patient specific information in the context of the DBS population at large so as to improve surgical implant targeting and post-implant programming efficiency. To date there is no other universal tool that meets this need.
A universal atlas database (Cranial Vault) with software interface (CRAVE) is novel and has global relevance to clinicians, patients, and industry involved with deep brain stimulator (DBS) implants. It is already successfully transforming the surgery and management of DBS implants at one major medical center (Vanderbilt University). Completion of this project will test the ability of the atlas to interface and be useful for all centers that implant and manage DBS therapy in patients.
